Corticotropin Powder
NDC Package 59149-005-53

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

This product is an UNFINISHED DRUG part of the official NDC directory. Unfinished drugs include products like active ingredients some of which are used in bulk for further processing or compounding. The FDA requires a list of these drugs manufactured in a U.S. commercial distribution facility.

Corticotropin powders is a medication used to treat a certain type of seizure in children (infantile spasms). This formulation utilizes a powder delivery system. Marketed by Polypeptide Laboratories, Pvt. Ltd., this product is identified by NDC 59149-005.

Identification & Billing

NDC Package Code
59149-005-53
Package Description
500 g in 1 BOTTLE, PLASTIC
Product Code
59149-005
11-Digit Billing Format
59149000553

Clinical Specifications

Proprietary Name
Corticotropin
Non-Proprietary Name
Corticotropin
Substance Name
Corticotropin
Dosage Form
Powder - An intimate mixture of dry, finely divided drugs and/or chemicals that may be intended for internal or external use.
Active Ingredient(s)
CORTICOTROPIN 350 g/350g
Usage Information
This medication is used to treat a certain type of seizure in children (infantile spasms). This medication is also used to treat conditions such as multiple sclerosis, arthritis, lupus, eye conditions, skin/kidney/lung diseases, and immune system disorders. It decreases your immune system's response to various diseases to reduce symptoms such as swelling, pain, and allergic-type reactions. Corticotropin is a hormone.

Regulatory & Marketing

Labeler Name
Polypeptide Laboratories, Pvt. Ltd.
Product Type
Bulk Ingredient
Marketing Category
BULK INGREDIENT - A category specifying that a product is marketed as a bulk ingredient.
Start Marketing Date
04-11-2023
Listing Expiration
12-31-2026
Exclude Flag
N
Unfinished Product
Yes
Sample Package
N/A

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (59149-005). Click a package code to view its specific billing and regulatory data.

59149-005-01
1 g in 1 BOTTLE, PLASTIC
59149-005-51
350 g in 1 BOTTLE, PLASTIC
59149-005-52
1000 g in 1 BOTTLE, PLASTIC
59149-005-54
250 g in 1 BOTTLE, PLASTIC
59149-005-55
125 g in 1 BOTTLE, PLASTIC
59149-005-57
60 g in 1 BOTTLE, PLASTIC
59149-005-58
30 g in 1 BOTTLE, PLASTIC
59149-005-59
4 g in 1 BOTTLE, PLASTIC

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 59149-005-53 identifies a specific commercial package of 500 g in 1 bottle, plastic of Corticotropin (UNFINISHED drug), a bulk ingredient labeled by Polypeptide Laboratories, Pvt. Ltd.. This powder is formulated for use and contains corticotropin as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Polypeptide Laboratories, Pvt. Ltd. on April 11, 2023. The current certification is valid through December 31, 2026.

What are the primary indications for this medication?

This medication is used to treat a certain type of seizure in children (infantile spasms). This medication is also used to treat conditions such as multiple sclerosis, arthritis, lupus, eye conditions, skin/kidney/lung diseases, and immune system disorders. It decreases your immune system's response to various diseases to reduce symptoms such as swelling, pain, and allergic-type reactions. Corticotropin is a hormone.

How is this Polypeptide Laboratories, Pvt. Ltd. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 59149000553. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
59149-005-53
11-Digit CMS (5-4-2)
59149-0005-53

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.